October 16, 2023

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa (HS) Maintenance treatment with sonelokimab dosed every 4 weeks (Q4W), demonstrated that 57%

Read More ➜

PSEi tracks Asian markets, peso ends sideways

The Philippine Stock Exchange index (PSEi) on Monday tracked major Asian markets, closing the day in the red territory, while the peso moved sideways. PSEi finished the day dropping below the 6,200-mark by 67.51 points to 6,198.83 level, with

Read More ➜